UNH 2X Long ETF

$Unitedhealth(UNH.US) | Bernstein SocGen Group 𝗿𝗲𝗶𝘁𝗲𝗿𝗮𝘁𝗲𝘀 𝗢𝘂𝘁𝗽𝗲𝗿𝗳𝗼𝗿𝗺 on 𝗨𝗻𝗶𝘁𝗲𝗱𝗛𝗲𝗮𝗹𝘁𝗵 𝗚𝗿𝗼𝘂𝗽, maintains PT at $𝟱𝟭𝟮

Here's a conveniently timed Trump trade

$Unitedhealth(UNH.US)UnitedHealth closed at $401.67, down 13% from its July high of $461.62 but up 58% from its May 2025 crash low. Q2 2026 EPS surged 61.5% YoY to $6.04 with FCF nearly doubling, though revenue growth flattened near zero. Multiple daily oscillators flash oversold with Bollinger lower-band support at $396 being tested. Forward PE sits at 25.4x, near its 5-year median, while dividend yield has climbed to a 5-year high of 2.24%.

Here is every top $SPY performer (RP>85) currently sitting near the 50 day SMA 👀

$Unitedhealth(UNH.US)UnitedHealth (UNH) is showing a solid recovery in my portfolio, currently sitting at +18.44% with the market price around $407.08 versus my average cost of $343.33. I’m still holding with a longer-term view, as I believe the recent weakness created an attractive entry point. The recovery has been encouraging, but I’m staying patient and watching the company’s fundamentals and future growth closely. #TradeShowcase

$Unitedhealth(UNH.US)Holding UnitedHealth through the volatility is finally paying off. My position is now sitting at +20.38%, and this is a great reminder that patience often rewards investors who stick to their conviction instead of reacting to every short-term headline. 📈

I’m not rushing to celebrate or lock in profits just yet. I’ll continue monitoring earnings, business fundamentals, and the overall healthcare sector before making my next move. Every successful investment reinforces the importance of having a plan, managing risk, and letting time work in your favor. Wishing everyone green portfolios and disciplined investing! 💪📊🚀

$Unitedhealth(UNH.US)UNH closed at $419.08 on Friday, sitting right on the 30-day MA (~$419) after pulling back from the $434 Bollinger upper band. A few things I’m watching closely:

Technicals are flashing caution, but also potential support. KDJ is deeply oversold (K at 24, J at 9), ARBR shows an extremely oversold BR reading, and the PSY indicator just broke below its moving average — short-term selling pressure is real. However, MACD remains above the zero line, meaning the broader uptrend hasn’t fully reversed yet.

The setup matters. Price is now testing the 30-day MA as support. If this level holds, it could be a solid re-entry zone for those who missed the prior leg up. A break below $415 (Bollinger lower band) would change the picture.

$Unitedhealth(UNH.US) | BofA Securities reiterates 𝐁𝐮𝐲 on 𝐔𝐧𝐢𝐭𝐞𝐝𝐇𝐞𝐚𝐥𝐭𝐡 𝐆𝐫𝐨𝐮𝐩, 𝐫𝐚𝐢𝐬𝐞𝐬 𝐏𝐓 𝐭𝐨 $𝟓𝟏𝟐

$Unitedhealth(UNH.US)+23.30% on UNH and still holding. This position has been a great reminder that patience often pays off. While market sentiment around UnitedHealth has been volatile, I chose to stay focused on the company’s long-term fundamentals instead of reacting to short-term price swings. Today’s gain is encouraging, but I’m not treating it as the finish line. I’ll continue monitoring earnings, regulatory developments, and business execution while letting the investment thesis play out. Staying disciplined and avoiding emotional decisions has been one of the biggest lessons from this trade. Looking forward to seeing how this position performs over the long run.

$Unitedhealth(UNH.US) | Baird 𝐮𝐩𝐠𝐫𝐚𝐝𝐞𝐬 𝐔𝐧𝐢𝐭𝐞𝐝𝐇𝐞𝐚𝐥𝐭𝐡 𝐆𝐫𝐨𝐮𝐩 to 𝐍𝐞𝐮𝐭𝐫𝐚𝐥, 𝐫𝐚𝐢𝐬𝐞𝐬 𝐏𝐓 𝐭𝐨 $𝟒𝟓𝟑 from $𝟐𝟖𝟕